InBody Co.Ltd (041830.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · South Korea · ISIN KR7041830001
InBody Co.Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 204.46 bn KRW | 233.95 bn KRW |
| Gross profit | 158.23 bn KRW | 181.01 bn KRW |
| Operating income | 36.74 bn KRW | 36.75 bn KRW |
| EBIT | 44.23 bn KRW | 39.11 bn KRW |
| Net income | 33.14 bn KRW | 30.63 bn KRW |
| Diluted EPS – continuing operations | 2,544.19 KRW | 2,512.48 KRW |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About InBody Co.Ltd
InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.
More stocks
- Colonial Coal International Corp (CAD.V)
- First Copper Technology Co Ltd (2009.TW)
- Enjoyor (300020.SZ)
- Hamborner REIT (HABA.DE)
- Guangdong Huiyun Titanium Industry (300891.SZ)
- Hartadinata Abadi Tbk PT (HRTA.JK)
- Shandong Yabo Technology Co Ltd (002323.SZ)
- Shaanxi Broadcast & TV Network Intermediary Group Co Ltd (600831.SS)
- Duratec Ltd (DUR.AX)
- Aekyung Petrochemical Co Ltd (161000.KS)
- Napatech A/S (NAPA.OL)
- Beijing InterAct Technology Co Ltd (300419.SZ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.